Exploratory linear mixed-effects analyses were conducted to examine changes in Glu/tNAA and Gln/tNAA from baseline across infusion blocks, using the same model parameters as the primary Glx/tNAA change analysis
Further, KD should not be used in patients with chronic kidney disease, liver failure, hypertriglyceridemia-induced acute pancreatitis, heart failure, especially NYHA Class IV, eating disorders, respiratory failure, as well as in the elderly, and during pregnancy and lactation ( KD is widely used as an adjuvant therapy for many diseases
Together, they form a trifecta of regeneration, addressing issues from the inside out
Mol Pharmacol 59:13601368 [DOI] [PubMed] [Google Scholar] McLaughlin NJ, Banerjee A, Kelher MR, Gamboni-Robertson F, Hamiel C, Sheppard FR, Moore EE, Silliman CC
3234 There is some published evidence on oral treatment with glutathione especially its absorption from the gastrointestinal tract